None of the identified published studies contained cost information relating to the Debrisoft pad. The Soares (2009) study, which reported results from the VenUS II trial, was used to provide clinical ...
The National Institute for Health and Care Excellence recommends patented monofilament fibre technology, Debrisoft, for the treatment of acute and chronic wounds in the NHS There are 2.2 million ...
achieve more effective debridement facilitating initial assessment, which may result in less frequent and fewer overall care visits reduce the amount of community care needed, leading to reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results